Maven Clinic
A virtual clinic for fertility, pregnancy, parenting and menopause, sold mainly through 2,300+ employers and health plans. Last valued at a reported $1.7B in 2024, now also selling direct to women.
Maven, Mar 11, 2026; CNBC, Oct 8, 2024- Valuation
- $1.7B (reported) at the October 2024 Series F, per CNBC and Reuters; Maven's own release gave no figure. Up from $1.35B in 2022.
- Raised
- $425M+ Maven's own total across rounds from 2015 to 2024; the last priced round was $125M in October 2024.
- Reach
- 28M+ covered lives up from 23M in mid 2025 and 17M in 2024, across 2,300+ employers and health plans. No revenue figure is published.
- Watch
- IPO-tested executives 2025 hires include a CFO who took Alight public and a legal chief who guided Life360 through its IPO.
- AI
- Maven Intelligence an AI layer launched March 2026 that routes members to care and benefits, with NVIDIA guardrails. No public MCP server found.
- Liquidity
- None reported no staff tender offer found. Shares trade only on secondary platforms for accredited investors; not listed.
- Hiring
- 31 → 29 remote listings since Oct 10.
Paid by employers and health plans, now also by consumers.
Most revenue comes from Maven Enterprise: employers and health plans buy programs for fertility and family building, maternity, parenting and pediatrics, and menopause for their members. Maven Managed Benefit also administers fertility benefit dollars. In 2026 it added consumer subscriptions for virtual care, GLP-1 and hormone care; employers can add those from 2027. No prices or revenue split are published.
Maven, Mar 11, 2026; Maven, Oct 8, 2024- 1Locked into big employer benefitsOver 2,300 employers and health plans, with named clients including Amazon, Microsoft, AT&T, Morgan Stanley and L'Oreal. Benefits contracts tend to renew yearly.Maven, Oct 8, 2024; Maven, Mar 2026
- 2Its own outcomes evidenceMaven runs a Clinical Research Institute and reports 32% fewer NICU admissions for high-risk pregnancies versus a national survey benchmark. These are company studies, not independent trials.Maven, Aug 27, 2026
- 3One vendor for every life stagePrograms run from fertility through menopause, with 30+ specialties and 475+ fertility clinics in network. Rivals like Progyny and Midi focus on one stage.Maven, Oct 8, 2024
- Hims & Hers$6.46Blisted, Oct 30 close
- Maven Clinic$1.70BSeries F, Oct 8
- Teladoc Health$1.55Blisted, Oct 30 close
- Midi Health$1.00Bprivate, Feb 3
Private values are the last reported round; they can be stale. Listed values are market value. Bars start at zero.
Every round, and what its terms give away.
Maven Clinic is private, so there is no share price. What its investors paid, and on what terms, is the closest thing to one.
- $1.70B
- latest valuation, Series F Oct 8
- $425M
- raised in all
Post-money valuations as reported. The line starts at zero. Rounds without a reported valuation are left off.
- Oct 8Series F$125M at $1.70BLed by StepStone Group. About 7% of the company, if all new sharesValuation reported by CNBC and Reuters, not stated in Maven's release. Existing backers including General Catalyst and Sequoia joined.Maven release, Oct 8, 2024; CNBC
- Nov 14Series E$90M at $1.35BLed by General Catalyst. About 7% of the company, if all new sharesCVS Health Ventures and Intermountain Ventures joined. Raised during a market downturn.Fortune, Nov 14, 2022; HIT Consultant
- Aug 17Series D$110MLed by Dragoneer Investment Group and Lux CapitalValued at more than $1B, an exact figure was not reported. Oprah Winfrey invested.MedCity News, Aug 17, 2021
- Feb 19Series C$45MLed by Icon VenturesReese Witherspoon, Natalie Portman and Mindy Kaling among individual investors.HIT Consultant, Feb 19, 2020
- Sep 26Series B$27MLed by Sequoia Capital and Oak HC/FTTotal raised reached $42M. Both leads took board seats.Maven release via BioSpace, Sep 26, 2018
- Nov 212017 equity round (Form D)$11MLed by Not named in filingForm D filed Nov 21, 2017: $10.87M of equity sold to 22 investors, first sale June 2017.SEC Form D, Maven Clinic Co., filed Nov 21, 2017
- Down round or flat round?No. The reported $1.7B Series F valuation is about 26% above the $1.35B Series E of 2022.CNBC, Oct 2024; Fortune, Nov 2022Clear
- How much of the company the last round soldAbout 7%: $125M at a reported $1.7B. Reports do not say if $1.7B is pre or post money.CNBC via NBC Los Angeles, Oct 8, 2024Clear
- Time since the last raiseAbout 25 months since October 2024, the longest gap since 2020. Maven publishes no cash, burn or profit figures, so runway cannot be checked.Maven release, Oct 8, 2024Open
- Structured or unusual termsNone reported. Maven's SEC filer page shows no Form D after 2017, so later round terms cannot be checked there.SEC EDGAR filing list, checked Nov 3, 2026Open
- Who led the last roundStepStone Group, a new lead not named in earlier rounds. Six existing investors followed.Maven release, Oct 8, 2024Clear
- Tender offers or secondary sales for staffNo company tender found in Maven's press page or news. Secondary platforms list the stock, but that is not a staff program.Maven press page, checked Nov 3, 2026Open
- Layoffs in the last 12 monthsNone found since November 2025. Earlier, HIStalk reported a 10% cut in November 2024, weeks after the Series F; Maven did not announce it.Mediformatica summary of HIStalk, Nov 3, 2024; searched Nov 3, 2026Clear
Clear: checked, nothing found. Flag: found, with the source. Open: could not be checked.
No filing reported
What the record says, and what we think it means.
The fact is the source's. The read, in italics, is ours.
- 01Watch
It now sells straight to women.
Maven, Mar 11, 2026; TIME, Mar 2026In March 2026 Maven opened subscriptions to any US woman for virtual care, GLP-1 and hormone care, after a decade of employer-only access. Pricing was not disclosed.
A new revenue line, but it puts Maven against consumer brands that spend heavily on ads, a different skill from selling to HR teams.
- 02Neutral
An IPO-ready C-suite was hired in 2025.
Maven release (syndicated), Jun 16, 2025CFO Katie Rooney led Alight's IPO; legal chief Susan Stick guided Life360 through its IPO. Both joined in the first half of 2025.
Hires like these often come before a listing. Nothing has been filed.
- 03Neutral
The CEO said no IPO filing soon.
Fortune, Oct 9, 2024In October 2024 Kate Ryder said going public does not look fun right now and Maven is not filing anytime soon, though it expects an IPO in future.
That was two years ago. No newer statement either way was found.
- 04Watch
A reported 10% cut after the 2024 raise.
Mediformatica summary of HIStalk, Nov 3, 2024HIStalk reported Maven laid off 10% of headcount in early November 2024, weeks after raising $125M. We found no company statement.
Cuts right after a raise suggest a push on costs. None have been reported since.
- 05Good
Covered lives keep climbing.
Maven, Mar 2026; Jun 2025; HIT Consultant, Nov 2022Maven reported 15M lives under management in 2022, 17M in 2024, 23M in mid 2025 and 28M+ in March 2026.
Lives covered is not revenue, since many members never use the service. But steady growth means more contracts.
- 06Neutral
Outcome claims come from its own studies.
Maven, Aug 27, 2026Maven reports 32% fewer NICU admissions among 9,328 high-risk members versus a CDC survey benchmark, run by its own research institute.
Useful for selling to employers, but it is not a randomized trial and the release does not say it was peer reviewed.
- 07Watch
Hybrid, not fully remote.
Maven Greenhouse posting, checked Nov 3, 2026Postings say New York staff work onsite Tuesday to Thursday. Staff in Boston, DC, Chicago, Seattle and San Francisco attend monthly in-person days. 17 of 29 listings say New York or remote in hub cities.
Remote mostly means living near a hub city. Check each listing's location line.
Engineering is paid 12% over market.
We save every company's roles, pay by team and level, AI share and churn every day, so each month this page can say more. Sparklines use their own scale.
Can AI agents do business with Maven Clinic?
We checked the agent payment programs, developer docs and site rules an AI assistant would meet.
AI inside, closed to outside agents. Maven runs its own agentic care layer, but offers no MCP server, public API or llms.txt.
Still Remote read- YesIts own AI agentMaven Intelligence, launched March 17, 2026, uses agentic coordination to route members to providers, benefits and follow-ups, with NVIDIA NeMo Guardrails.Maven, Mar 17, 2026
- Not foundAn MCP server or API agents can callNo MCP server, developer docs or public API found. /.well-known/mcp.json returns 404.checked Nov 3, 2026
- Not foundA guide for AI tools (llms.txt)mavenclinic.com/llms.txt returns the site's web page shell, not a text file.checked Nov 3, 2026
- MixedLets AI crawlers read its siterobots.txt names no AI bots. It blocks every crawler from /app/ and from /resources/, its health content library.checked Nov 3, 2026
- YesClear rules on member data and AIMaven says member conversations are never sold or used to train outside models, and AI features pass clinical review before release.Maven, Mar 17, 2026
Where Maven Clinic puts AI to work.
- 1AI cuts clinician paperworkMaven says AI across its platform cut post-appointment documentation time by 30%, and that AI supports rather than replaces clinical decisions.Maven, Mar 17, 2026
- 2Builds on OpenAI and Gemini modelsA current Staff AI/ML engineer posting describes RAG and agent frameworks on models such as OpenAI and Gemini, for care routing, decision support and summarization. Posted pay is $220,000 to $300,000.Maven Greenhouse posting, checked Nov 3, 2026
As many listings as on Sep 7, led by engineering.
What has to be true for $1.7 billion to hold?
Maven Clinic does not publish revenue, so the starting number is your assumption, not ours. A way to think, not a forecast, and not investment advice.
At 25x, Maven Clinic needs $68 million of revenue to be worth $1.7 billion. Your world gets there with $133 million, so the next round likely prices above the last.
$100,000 of equity valued at the $1.70B Series F price would be worth about $196,000 on paper in this world, before dilution from new rounds, taxes and vesting. Private shares only turn into cash at a sale, an IPO or a tender offer.
A way to think, not a forecast, and not investment advice.
CNBC, Oct 8, 2024; Maven releaseThe signals, and which way they push.
- TailwindEmployers keep adding family benefits.
Maven cites survey data that nearly 70% of employers plan to expand family benefits vendors within two to three years, and grew clients 170% in a year.
- TailwindFertility coverage rules are spreading.
Maven is pitching tools to employers as fertility benefits legislation takes shape, which could widen the market for benefit administration.
- HeadwindFunded rivals in menopause and midlife.
Midi Health raised $100M at over $1B in February 2026, while Maven has not raised since 2024.
- HeadwindA crowded GLP-1 consumer market.
Maven's consumer launch leads with GLP-1 and hormone care, a space where listed telehealth firms like Hims & Hers already sell.
Where Maven Clinic ends up, if we had to bet.
Our calls, not facts. Each one is tied to something that already happened, so you can judge the reasoning.
- 1
Maven lists on a US exchange by 2031.
Coin flip 50%IPOIt hired a CFO and legal chief who have taken companies public. But the CEO said in 2024 it was not filing soon, and no revenue or profit has been disclosed.
Maven, Jun 2025; Fortune, Oct 2024 - 2
Maven raises new money or a debt facility before any IPO.
Likely 72%FundingThe last round was October 2024 and it has since launched a costly consumer business. Rivals like Midi are raising at $1B+ valuations.
Maven, Oct 2024; Mar 2026 - 3
Consumer subscriptions bring in more than employer contracts by 2031.
Long shot 16%RevenueThe enterprise base spans 2,300+ employers and 28M lives. The consumer business only launched in 2026 against well funded rivals.
Maven, Mar 11, 2026 - 4
Most member navigation at Maven is handled first by its AI layer.
Likely 72%AIMaven Intelligence already routes members to care and benefits. Maven plans to extend it to fertility and maternity programs during 2026.
Maven, Mar 17, 2026 - 5
Maven is bought by a large insurer or benefits company.
Long shot 16%M&ACVS Health Ventures invested in 2022, and health plans are both customers and possible buyers. But its executive hires point to a listing, not a sale.
HIT Consultant, Nov 14, 2022; Maven, Jun 2025
Read by the Still Remote research agent on November 3, 2026 from the sources linked on this page. Facts and scenarios only, not investment advice.